CV Sciences, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $706.00K.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $552.00K.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-09-30 was $328.00K.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-06-30 was $389.00K.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $1.95M, a 626.12% increase from fiscal 2021.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $268.00K.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $1.80M, a 209.61% increase from fiscal 2016.
- CV Sciences, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $583.00K, a 25.10% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $706.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $552.00K 10-Q · filed 2026-08-13 | |
| 2022-12-31 | $1.95M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $328.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $389.00K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $1.23M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $268.00K 10-K · filed 2023-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $150.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $480.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-14 | $755.00K derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.80M 10-K · filed 2019-03-12 |
| 2017-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.83M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $275.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $1.50M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $1.05M 10-Q · filed 2018-05-14 | $1.23M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $583.00K 10-K · filed 2018-03-30 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2016-03-31 | $408.00K 10-Q · filed 2017-05-09 | |
| 2015-12-31 | $778.37K 10-K · filed 2017-03-31 | |
| 2014-12-31 | $6.00M 10-K · filed 2016-04-14 |